Dilation group | Aneurysm group | P value | |
---|---|---|---|
N = 413 (89.0%) | N = 51 (11.0%) | ||
Age (months) | 18.3 (10.6–28.4) | 35.7 (15.1–63.8) | <0.001* |
Weight (kg) | 11.0 (9.4–13.0) | 14.0 (11.0–20.0) | 0.002* |
Sex (M/F) | 308/105 | 43/8 | 0.175 |
KD type | 0.799 | ||
Complete | 321 (77.7%) | 41 (80.4%) | |
Incomplete | 92 (22.3%) | 10 (19.6%) | |
Symptoms | |||
Fever | 410 (99.3%) | 51 (100%) | 0.999 |
LN enlargement | 181 (43.8%) | 22 (43.1%) | 0.999 |
Rash | 312 (75.5%) | 29 (56.9%) | 0.007* |
Conjunctivitis | 377 (91.3%) | 48 (94.1%) | 0.674 |
Oral changes | 366 (88.6%) | 39 (76.5%) | 0.025* |
Extremity changes | 287 (69.5%) | 32 (62.7%) | 0.412 |
Delayed IVIG treatment | 45 (10.9%) | 12(23.5%) | 0.018* |
IVIG-resistant | 32 (7.7%) | 7 (13.7%) | 0.236 |
CAL types | <0.001* | ||
Single | 32 7 (79.2%) | 15 (29.4%) | |
Multiple | 86 (20.8%) | 36 (70.6%) |